英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作

新浪港股

07/13

熱點欄目自選股數據中心行情中心資金流向模擬交易

客戶端

　　英硅智能（03696）早盤升逾7%，截至發稿，股價上漲6.21%，報45.48港元，成交額3.32億港元。

　　7月13日，據英硅智能官微消息，公司宣佈與康哲藥業（00867）在中樞神經系統領域開展另一項AI驅動的藥物發現合作。該合作針對某巨大市場的適應症，並基於PandaOmics識別出的創新作用機制（MoA）展開。

　　根據合作協議，雙方將結合英硅智能已驗證的AI平台與AI賦能創新藥研發能力，以及康哲藥業經驗豐富的研發團隊和對疾病領域的深度認知，雙方共同推進該研發項目的合作開發。同時，英硅智能有望獲得總額最高約12億人民幣的里程碑付款及淨銷售額分成。此次合作標誌着雙方關係的進一步深化，旨在充分發揮雙方在藥物發現、臨床開發及商業化全價值鏈中的優勢互補。

海量資訊、精準解讀，盡在新浪財經APP

責任編輯：盧昱君

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2651162210"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2651162210\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2651162210?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-07-13 10:02","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2651162210","market":"sg","top_or_hot":-1,"title":"英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作","media":"新浪港股","content":"<html><body><div>\n<div>\n<div>\n<img src=\"http://image.sinajs.cn/n/hk/min/640x360xxfhd/03696.png\"/>\n</div>\n<div>\n<div>\n<span>熱點欄目</span>\n<s></s>\n自選股\n數據中心\n行情中心\n資金流向\n模擬交易\n</div>\n客戶端\n</div>\n</div>\n<p>　　英硅智能（03696）早盤升逾7%，截至發稿，股價上漲6.21%，報45.48港元，成交額3.32億港元。</p>\n<p>　　7月13日，據英硅智能官微消息，公司宣佈與<span><a href=\"https://laohu8.com/S/00867\">康哲藥業</a></span><span></span>（00867）在中樞神經系統領域開展另一項AI驅動的藥物發現合作。該合作針對某巨大市場的適應症，並基於PandaOmics識別出的創新作用機制（MoA）展開。</p>\n<p>　　根據合作協議，雙方將結合英硅智能已驗證的AI平台與AI賦能創新藥研發能力，以及康哲藥業經驗豐富的研發團隊和對疾病領域的深度認知，雙方共同推進該研發項目的合作開發。同時，英硅智能有望獲得總額最高約12億人民幣的里程碑付款及淨銷售額分成。此次合作標誌着雙方關係的進一步深化，旨在充分發揮雙方在藥物發現、臨床開發及商業化全價值鏈中的優勢互補。</p>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n<p>責任編輯：盧昱君 </p>\n</div></body></html>","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">新浪港股</strong><span class=\"h-time small\">2026-07-13 10:02</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<div>\n<div>\n<img src=\"http://image.sinajs.cn/n/hk/min/640x360xxfhd/03696.png\"/>\n</div>\n<div>\n<div>\n<span>熱點欄目</span>\n<s></s>\n自選股\n數據中心\n行情中心\n資金流向\n模擬交易\n</div>\n客戶端\n</div>\n</div>\n<p>　　英硅智能（03696）早盤升逾7%，截至發稿，股價上漲6.21%，報45.48港元，成交額3.32億港元。</p>\n<p>　　7月13日，據英硅智能官微消息，公司宣佈與<span><a href=\"https://laohu8.com/S/00867\">康哲藥業</a></span><span></span>（00867）在中樞神經系統領域開展另一項AI驅動的藥物發現合作。該合作針對某巨大市場的適應症，並基於PandaOmics識別出的創新作用機制（MoA）展開。</p>\n<p>　　根據合作協議，雙方將結合英硅智能已驗證的AI平台與AI賦能創新藥研發能力，以及康哲藥業經驗豐富的研發團隊和對疾病領域的深度認知，雙方共同推進該研發項目的合作開發。同時，英硅智能有望獲得總額最高約12億人民幣的里程碑付款及淨銷售額分成。此次合作標誌着雙方關係的進一步深化，旨在充分發揮雙方在藥物發現、臨床開發及商業化全價值鏈中的優勢互補。</p>\n<div>\n<div><img src=\"\"/></div>\n<div>海量資訊、精準解讀，盡在新浪財經APP</div>\n</div>\n<p>責任編輯：盧昱君 </p>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml\">新浪港股</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BVYPNQ40.USD","symbol_name":"GUINNESS ASIAN EQUITY INCOME \"C\" (USD) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml","article_id":"2651162210","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2651162210","pubTimestamp":1783908120,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"　　英硅智能早盤升逾7%，截至發稿，股價上漲6.21%，報45.48港元，成交額3.32億港元。　　7月13日，據英硅智能官微消息，公司宣佈與康哲藥業在中樞神經系統領域開展另一項AI驅動的藥物發現合作。　　根據合作協議，雙方將結合英硅智能已驗證的AI平台與AI賦能創新藥研發能力，以及康哲藥業經驗豐富的研發團隊和對疾病領域的深度認知，雙方共同推進該研發項目的合作開發。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00BVYPNQ40.USD":"GUINNESS ASIAN EQUITY INCOME \"C\" (USD) ACC","SG9999015978.USD":"利安颠覆性创新基金A","IE00BVYPNP33.GBP":"GUINNESS ASIAN EQUITY INCOME \"C\" (GBP) ACC","ARTY":"ISHARES FUTURE AI & TECH ETF","AGIX":"通用人工智能 ETF-AGIX","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","BK4588":"碎股","WRND":"NYLI Global Equity R&D Leaders ETF","IE00BGHQDM52.EUR":"GUINNESS ASIAN EQUITY INCOME \"C\" (EUR) ACC","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","PBE":"INVESCO BIOTECHNOLOGY & GENOME ETF","GDOC":"Goldman Sachs Future Health Care Equity ETF","LFSC":"F/m Emerald Life Sciences Innovation ETF","GSKH":"GSK plc ADRhedged","SBIO":"ALPS Medical Breakthroughs ETF","IE00BYV24P56.USD":"GUINNESS EMERGING MARKETS EQUITY INCOME \"C\" (USD) ACC","IE00BMCWC346.EUR":"GUINNESS EMERGING MARKETS EQUITY INCOME \"C\" (EUR) ACC","BK1191":"制药","BBP":"Virtus LifeSci Biotech Products ETF","BK1593":"医美概念股","IBB":"生物科技指数ETF-iShares Nasdaq","QTOC":"Innovator Growth Accelerated Plus ETF - October","00867":"康哲药业","BK4585":"ETF&股票定投概念","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","VTHR":"Vanguard Russell 3000 ETF","AIPO":"Defiance AI and Power Infrastructure ETF"},"translate_title":"Yingsi Intelligent rose more than 7% in early trading and reached a new cooperation with Kangzhe Pharmaceutical in AI + innovative drug research and development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00867":1.5,"ARTY":1.5,"WRND":1.5,"BBP":1.5,"CHAT":1.5,"LFSC":1.5,"GSKH":1.5,"AIPO":1.5,"SBIO":1.5,"VTHR":1.5,"IBB":1.5,"QTOC":1.5,"PBE":1.5,"GDOC":1.5,"AGIX":1.5},"content_text":"熱點欄目\n\n自選股\n數據中心\n行情中心\n資金流向\n模擬交易\n\n客户端\n\n\n　　英硅智能（03696）早盤升逾7%，截至發稿，股價上漲6.21%，報45.48港元，成交額3.32億港元。\n　　7月13日，據英硅智能官微消息，公司宣佈與康哲藥業（00867）在中樞神經系統領域開展另一項AI驅動的藥物發現合作。該合作針對某巨大市場的適應症，並基於PandaOmics識別出的創新作用機制（MoA）展開。\n　　根據合作協議，雙方將結合英硅智能已驗證的AI平台與AI賦能創新藥研發能力，以及康哲藥業經驗豐富的研發團隊和對疾病領域的深度認知，雙方共同推進該研發項目的合作開發。同時，英硅智能有望獲得總額最高約12億人民幣的里程碑付款及淨銷售額分成。此次合作標誌着雙方關係的進一步深化，旨在充分發揮雙方在藥物發現、臨床開發及商業化全價值鏈中的優勢互補。\n\n\n海量資訊、精準解讀，盡在新浪財經APP\n\n責任編輯：盧昱君","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}